These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24780460)

  • 21. Epigenetic mechanisms in the pathogenesis of diabetic retinopathy.
    Zeng J; Chen B
    Ophthalmologica; 2014; 232(1):1-9. PubMed ID: 24714375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers.
    Rafehi H; El-Osta A; Karagiannis TC
    J Diabetes Complications; 2012; 26(6):554-61. PubMed ID: 22739801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between glucose control and the development of diabetic nephropathy in type I diabetes.
    Molitch ME
    Semin Nephrol; 1997 Mar; 17(2):101-13. PubMed ID: 9148376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of controlling diabetes early--the concept of metabolic memory, legacy effect and the case for early insulinisation.
    Ranjit Unnikrishnan I; Anjana RM; Mohan V
    J Assoc Physicians India; 2011 Apr; 59 Suppl():8-12. PubMed ID: 21818992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia.
    Choe C; Edelman SV
    South Med J; 2007 Nov; 100(11):1123-31. PubMed ID: 17984745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycemic control and complications in type 2 diabetes mellitus.
    Stolar M
    Am J Med; 2010 Mar; 123(3 Suppl):S3-11. PubMed ID: 20206730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy -- a multifaceted target of new therapies.
    Choudhury D; Tuncel M; Levi M
    Discov Med; 2010 Nov; 10(54):406-15. PubMed ID: 21122472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Control of diabetes and late complications].
    Chabot V; Kappeler H; Morell B
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1192-8. PubMed ID: 2237045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
    Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
    Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic memory.
    El-Osta A
    Curr Opin Lipidol; 2012 Feb; 23(1):24-9. PubMed ID: 22186662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of "metabolic memory" in the natural history of diabetes mellitus.
    Drzewoski J; Kasznicki J; Trojanowski Z
    Pol Arch Med Wewn; 2009; 119(7-8):493-500. PubMed ID: 19776690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic changes in diabetes.
    Keating ST; El-Osta A
    Clin Genet; 2013 Jul; 84(1):1-10. PubMed ID: 23398084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic mechanisms.
    Villeneuve LM; Natarajan R
    Contrib Nephrol; 2011; 170():57-65. PubMed ID: 21659758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.